直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • 生命科学
    • Transportation and Logistics
  • 经验

数字医疗

About

数字医疗 是本所业务分支,下属于 消费品和服务业, 生命科学, 电子和信息科技, and 通信.

医疗保健与技术融合创造新机会

飞翰协助初创公司及成熟企业制定知识产权策略,以保护其用于数字医疗技术的创新解决方案,这些方案旨在降低成本,改善患者护理。 消费者可以获取越来越多价格适宜的便携式设备,这些设备专门提供有关个人健康和生活方式的各项指标和详情。在这个联系日益密切的世界中,这类个人信息对于帮助医护人员为患者提供更高水平的护理具有宝贵作用。我们还发现制药商正以前所未有的速度与数字医疗企业开展合作。数字治疗的市场多面性有望弥补甚至取代传统的临床治疗。由于现代医学日益复杂,逐渐超出人类记忆力极限——目前有数千种诊断、药物和内外科手术——数字医疗技术为提高患者护理和服务水平提供必要的工具。

精通法律、科学与技术

飞翰与企业共同制定知识产权策略,整体规划确保与技术创新的真正融合。飞翰的技术经验兼有深度和广度,涵盖从生命科学(生物技术、临床、诊断、医疗保健、制药、基因组学、生物信息学、医疗设备)到计算机和软件技术(如人工智能、大数据和云存储),再到工业制造、纳米技术、传感器和其他相关领域。

我们精通各种技术相对应的法律差异,在具体的法律问题上,由于某些类型的技术可能比其他技术更为敏感,因此,我们与客户密切合作,根据其核心业务目标、发展速度、市场准入难度、市场流动性、不断变化的联盟、复制难度和实施难度,制定获取知识产权保护的相应战略。我们还致力于评估当前行业动态、待立法案和判例法、潜在的产品和行业发展以及这些发展对客户知识产权地位的影响。我们还为在交叉领域进行创新的成熟企业提供咨询,恰当地利用机会促进其不同品牌的价值并使其保持一致。然后,我们会建议客户如何通过专利、版权和商业秘密达到保护和利用其创新的最佳效果,并针对他人带来的障碍给予客户引导。

在我们与推动边界创造新市场的数字医疗创新企业合作中,我们协助处理:

  • 由经验丰富的审判和上诉团队在地区法院和上诉法院为高价值产品代理诉讼;
  • 通过在美国本土和海外获得专利,开发和管理综合专利组合;
  • 将专利组合货币化产生额外的收入来源;
  • 分析竞争格局,并就客户自由开发新产品提供咨询意见;
  • 针对新技术和发展中的技术撰写意见并提供持续咨询服务;
  • 开展尽职调查;
  • 针对允许客户产品自由进入市场的许可协议开展谈判;
  • 就食品药品监管局与知识产权相关的规定提供引导;
  • 通过外观设计专利保护设置市场壁垒;
  • 提供商标保护和咨询。

该行业领域内的专业人员

经验

Utility and design patent applications for brain machine interface company

Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.

Healthbox Global Partners LLC v. Under Armour Inc.
Defeated Healthbox Global Partners, LLC’s motion for preliminary injunction asking the court to immediately order Under Armour to stop using HEALTHBOX/UA HEALTHBOX for its new connected fitness product, rebrand, and recall all products from store shelves.  After briefing and argument, the court ruled for Under Armour on all claims.

1:16-cv-00146, D. Del., Judge Robinson

Examiner's rejection reversed in favor of Finnegan client BrainScope
The Patent Trial and Appeal Board (PTAB) reversed a rejection of all patent claims in a patent application related to important neurodiagnostic device features for concussion and other brain abnormality assessments. Finnegan argued throughout the examination that the examiner had interpreted a claim limitation too broadly, and failed to appreciate the advance that the application claimed. After oral argument, the PTAB judges agreed and reversed the examiner's rejection on all grounds.
Full intellectual property service for a healthcare client developing wireless communication systems
A leading healthcare company that develops wireless communication systems for managing patient care turns to Finnegan for counsel in many different facets of intellectual property (IP). We study the patent landscape for wireless health management and assist the company in weaving its way through patents of its competitors; we obtain patent protection for its technology and trademark protection for its brands; and we provide guidance in drafting agreements for the transfer of technology.
Ensuring the broadest possible patent protection and expansion support
We provide in-depth patent prosecution and counseling services for one of the world's leading information management companies. Our service includes preparing patent applications directed to novel methods and systems for storing, protecting, and managing information with a particular focus on records management and data protection and recovery. In addition, we have provided due diligence for our client’s mergers and acquisitions, to assist it in achieving its strategic growth goals.
Patent strategy and portfolio development
Involved in ongoing patent strategy and portfolio development for multiple clients, including small startups through multi-national corporations. Representative clients include Mobileye, OrCam, Innoviz, AI21 Labs, Neuroblade, Adaptive 3D, Trax Technologies, Flatiron Health, among others.

专业见解

Federal Circuit IP Blog

Not an Abstract Way to Pump Iron: Federal Circuit Reverses Dismissal of Claims for Automatic Adjustable Dumbbells as Patent Ineligible

October 22, 2025

Articles

Navigating IP Challenges in the Wearable Tech Space

September 19, 2024

Webinar

Privacy and the Medical Device Industry

May 16, 2024

Webinar

Articles

Winning IP Strategies for Wearables

November 13, 2023

Conference

IAM Live: IP and Emerging Technology Europe 2023

April 19, 2023

London

Articles

D. Mass. Patent Litigation Update: September 2022

October 31, 2022

More

新闻

Press Release

Twelve Attorneys Elevated to Finnegan Partnership

January 7, 2025

Commentary

Future Apple Watch Sales Hinge on Next Steps in Patent Row

January 8, 2024

Apple Eyes Long-Term Software Fix for Watch While Appealing Ban

December 28, 2023

Commentary

Why the Apple Watch Is Being Banned – and How Apple Can Avoid It

December 19, 2023

Press Release

Finnegan Celebrates Two Wins at the 2020 LMG Life Sciences Awards and Top Honors in the Rankings

October 5, 2020

Media Mention

Who’s Arguing?

October 1, 2019

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP